Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
03/2009
03/19/2009US20090076274 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
03/19/2009US20090075994 Deuterium-enriched radafaxine
03/19/2009US20090075991 Deuterium-enriched efavirenz
03/19/2009US20090075989 Non-steroidal progesterone receptor modulators
03/19/2009US20090075973 Benzo-fused heterocycles
03/17/2009US7504537 osteoarthritis or rheumatoid arthritis
03/17/2009US7504495 Quencher compositions comprising anthraquinone moieties
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/12/2009US20090069533 Benzoxazine monomers, polymers and compositions
03/12/2009US20090069517 Ligands and catalyst systems for the oligomerization of olefinic monomers
03/12/2009US20090069331 Guanidine derivatives as inhibitors of ddah
03/12/2009US20090069309 Prostaglandin analogs
03/12/2009US20090068719 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics
03/12/2009US20090066224 Dicarbazole aromatic amine polymers and electronic devices
03/12/2009US20090065744 Use of polynuclear phenolic compounds as stabilisers
03/11/2009CN101384564A Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
03/11/2009CN101381361A Organic compound for recording layer and optical recording medium including the same
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501414 Substituted morpholine and thiomorpholine derivatives
03/10/2009US7501408 2-(R)-Cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-4-thiomorpholin-4-yl-butyramide; selective in presence of at least one other cathepsin isozyme; antiinflammatory agent: arthritis, atherosclerosis
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062286 Crystal Structure of SMYD3 Protein
03/05/2009US20090062285 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof
03/05/2009US20090062271 Antithrombotic Diamides
03/05/2009US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/04/2009EP2029588A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
03/04/2009EP1948626B1 Process for the preparation of delmopinol and derivatives thereof
03/04/2009EP1380306B1 Remedies for restless leg syndrome
03/04/2009CN101379048A Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/04/2009CN101379047A Preparation of delmopinol
03/04/2009CN101379044A Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/04/2009CN100465286C A preparation method of optically active propoxyaniline derivatives
02/2009
02/26/2009WO2009001203A3 An improved process for the preparation of aprepitant
02/26/2009US20090054439 Sulfonamide derivatives, preparation and therapeutic application thereof
02/26/2009US20090054438 Compositions and methods for inhibiting growth and metastasis of melanoma
02/26/2009US20090054417 Compounds and compositions as modulators of steroid hormone nuclear receptors
02/26/2009US20090054402 7-substituted indole mcl-1 inhibitors
02/25/2009EP2027087A2 Intracellular kinase inhibitors
02/25/2009EP1716126B1 Morpholine derivatives as norepinephrine reuptake inhibitors
02/25/2009CN101374822A Novel method for synthesis of 1,4-morpholine-2,5-diones
02/25/2009CN101374807A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
02/24/2009US7495096 Processes for the production of chinazoline alkaloids
02/19/2009WO2009022687A1 Phenylacetic acid compound
02/19/2009WO2008106128A3 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
02/19/2009US20090048258 Amide Compound
02/19/2009US20090048257 Compounds that modulate ppar activity, their preparation and use
02/19/2009US20090048240 1,3-oxazinan-2-one compounds; antibiotic resistance
02/19/2009CA2695757A1 Phenylacetic acid compound
02/18/2009EP2025338A1 New medicaments for the treatment of chronic ostructive pulmonary disease
02/18/2009CN101367774A Fluorenyl bi-benzoxazine monomer and method of preparing the same
02/17/2009US7491832 Reacting a pentafluorophenylsulfonyl halide with a fluorescein derivative; responds to hydrogen peroxide with high selectivity
02/17/2009US7491719 adrenergic blocking agents such as R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylamino]ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride, used for the treatment of repiratoty system disorders
02/17/2009US7491718 Aminopeptidase inhibitor; vision defects; administering to eye
02/12/2009US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
02/12/2009US20090042883 Antitumor agent
02/12/2009US20090042872 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same
02/12/2009US20090042730 Substituted Arylketones
02/12/2009US20090041786 e.g. 5-Fluoro-N4-(3-hydroxyphenyl)-N2-[4-(N-methyl)aminosulfonyl-3-methoxyphenyl]-2,4-pyrimidinediamine; tyrosine (JAK) kinases inhibitor; interleukin and tumor necrosis factor ligand; transplant rejection; T-cell mediated autoimmune disease
02/11/2009CN100460382C Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril
02/10/2009US7488822 Cyclocarbamate derivatives as progesterone receptor modulators
02/05/2009WO2009017671A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
02/05/2009WO2009017664A1 CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1
02/05/2009WO2009017190A1 Fused bicyclic compound
02/05/2009US20090036677 Preparation of Delmopinol
02/05/2009US20090036437 Pharmaceutical composition comprising phenoxazinium compound as an active ingredient
02/05/2009US20090036420 Benzamide derivatives and their use for treating cns disorders
02/05/2009CA2697168A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
02/05/2009CA2697147A1 Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
02/04/2009EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity
02/04/2009CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
02/04/2009CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
02/03/2009CA2420040C New phenylalanine derivatives
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
01/2009
01/29/2009US20090030200 Process of preparing optically active allyl compound
01/29/2009US20090030199 Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
01/29/2009US20090030119 Process for Preparing a Benzoxazinone
01/29/2009US20090029965 Vasopressin V1a Antagonists
01/28/2009EP2018166A2 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
01/28/2009CN101353341A Colorant reacted by oxyalkylene-substituted aminophenol intermediate
01/28/2009CN100455573C 1,4-benzoxazolezin-3-ketone compound microwave synthesis method
01/28/2009CN100455570C Quinolinone / benzoxazinone derivatives and uses thereof
01/27/2009US7482448 Compounds and compositions as cathepsin inhibitors
01/27/2009US7482344 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure
01/22/2009WO2009011567A1 Crystalline forms of efavirenz
01/22/2009WO2009010606A1 Derivatives of 2-alkyl-2h-1, 4-benzoxazin-3(4h)-one and 2-alkoxycarbonyl-2h-1, -benzoxazin-3(4h)-one, with phytotoxic activity
01/22/2009WO2008052737A3 Immunochemically equivalent hiv drug analogs
01/22/2009US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/22/2009US20090023903 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
01/22/2009US20090023736 Compounds for treating proliferative disorders
01/22/2009US20090023731 Soluble epoxide hydrolase inhibitors
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
01/22/2009US20090023716 Benzoxazines and Related Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid Receptor Modulating Agents
01/21/2009EP2016057A1 C-fms kinase inhibitors
01/21/2009EP1562939B1 Carboxamides
01/20/2009US7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/15/2009WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
01/15/2009US20090018333 Dihydropteridione derivatives, process for their manufacture and their use as medicament
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 112